Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer, pending approval of the claimants. Those cases have for decades caused financial and public relations trouble for J&J, which contends that its now-discontinued talc baby powder and other talc products are safe for consumers. About 99% of the talc-related lawsuits filed against J&J and its subsidiaries stem from ovarian cancer. The company recorded a charge of about $2.7 billion in the first quarter to raise its reserve for talc claims to about $11 billion. The deal, pending approval by claimants, would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management. Courts have rebuffed J&J’s two previous efforts to resolve the lawsuits through the bankruptcy of that subsidiary, which was created to absorb…
Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of…
Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of…
Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of…
The auditing firm for Trump Media and the auditor’s owner were charged Friday with “massive fraud” by the Securities and Exchange…
Sony Pictures and private equity firm Apollo Global Management have sent a letter to the Paramount Global board expressing interest in…
Strong demand and tight supply continue to push home values higher, even though mortgage rates are now moving higher…